Related references
Note: Only part of the references are listed.First-Trimester Screening for Trisomies 21, 18 and 13 by Ultrasound and Biochemical Testing
D. Wright et al.
FETAL DIAGNOSIS AND THERAPY (2014)
Competing Risk Model in Screening for Preeclampsia by Mean Arterial Pressure and Uterine Artery Pulsatility Index at 30-33 Weeks' Gestation
Ahmet Tayyar et al.
FETAL DIAGNOSIS AND THERAPY (2014)
Competing Risks Model in Screening for Preeclampsia by Serum Placental Growth Factor and Soluble fms-Like Tyrosine Kinase-1 at 30-33 Weeks' Gestation
Jonathan Lai et al.
FETAL DIAGNOSIS AND THERAPY (2014)
Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting
Elena Scazzocchio et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2013)
Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia A Prospective Multicenter Study
Lucy C. Chappell et al.
CIRCULATION (2013)
Competing Risks Model in Early Screening for Preeclampsia by Biophysical and Biochemical Markers
Ranjit Akolekar et al.
FETAL DIAGNOSIS AND THERAPY (2013)
Onset threshold of the plasma levels of soluble fms-like tyrosine kinase 1/placental growth factor ratio for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19-31 weeks of gestation
Akihide Ohkuchi et al.
HYPERTENSION RESEARCH (2013)
The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients
Stefan Verlohren et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia
Sarosh Rana et al.
CIRCULATION (2012)
Maternal Serum Placental Growth Factor in Prospective Screening for Aneuploidies at 8-13 Weeks' Gestation
Pranav Pandya et al.
FETAL DIAGNOSIS AND THERAPY (2012)
A Competing Risks Model in Early Screening for Preeclampsia
David Wright et al.
FETAL DIAGNOSIS AND THERAPY (2012)
Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis
Stephanie Roberge et al.
FETAL DIAGNOSIS AND THERAPY (2012)
Protocol for Measurement of Mean Arterial Pressure at 11-13 Weeks' Gestation
L. C. Y. Poon et al.
FETAL DIAGNOSIS AND THERAPY (2012)
Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction
Jeanne Sibiude et al.
PLOS ONE (2012)
Turning the Pyramid of Prenatal Care
Kypros H. Nicolaides
FETAL DIAGNOSIS AND THERAPY (2011)
Hypertensive Disorders in Pregnancy: Screening by Systolic Diastolic and Mean Arterial Pressure at 11-13 Weeks
Leona C. Y. Poon et al.
HYPERTENSION IN PREGNANCY (2011)
Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia
Tinnakorn Chaiworapongsa et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2011)
Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks
Ranjit Akolekar et al.
PRENATAL DIAGNOSIS (2011)
Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach
L. C. Y. Poon et al.
JOURNAL OF HUMAN HYPERTENSION (2010)
Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy A Meta-Analysis
Emmanuel Bujold et al.
OBSTETRICS AND GYNECOLOGY (2010)
First-Trimester Prediction of Hypertensive Disorders in Pregnancy
Leona C. Y. Poon et al.
HYPERTENSION (2009)
Pregnancy-associated plasma protein-A and C-reactive protein levels in pre-eclamptic and normotensive pregnant women at third trimester
Koksal Deveci et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2009)
Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial
Corine M. Koopmans et al.
LANCET (2009)
The Global Impact of Pre-eclampsia and Eclampsia
Lelia Duley
SEMINARS IN PERINATOLOGY (2009)
The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age
Offer Erez et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2008)
Maternal serum placental growth factor at 11+0 to 13+6 weeks of gestation in the prediction of pre-eclampsia
R. Akolekar et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2008)
First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics
K. O. Kagan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2008)
Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction
F. Crispi et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2008)
Prediction of pre-eclampsia by uterine artery Doppler imaging: relationship to gestational age at delivery and small-for-gestational age
C. K. H. Yu et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2008)
Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis
Jeltsje S. Cnossen et al.
BMJ-BRITISH MEDICAL JOURNAL (2008)
Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy
Laura A. Magee et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2008)
Uterine artery Doppler at 11+0 to 13+6 weeks in the prediction of pre-eclampsia
W. Plasencia et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2007)
Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion
Holger Stepan et al.
HYPERTENSION (2007)
First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia
K. Spencer et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2007)
Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler and PAPP-A at 11-14 weeks' gestation
A. Pilalis et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2007)
Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction
M Egbor et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2006)
Prediction of pregnancy complications by first-trimester maternal serum PAPP-A and free β-hCG and with second-trimester uterine artery Doppler
K Spencer et al.
PRENATAL DIAGNOSIS (2005)
An accurate automated blood pressure device for use in pregnancy and pre-eclampsia: the Microlife 3BTO-A
A Reinders et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2005)
Recommendations for blood pressure measurement in humans and experimental animals - Part 1: Blood pressure measurement in humans - A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research
TG Pickering et al.
HYPERTENSION (2005)
Circulating angiogenic factors and the risk of preeclampsia
RJ Levine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
First trimester placental growth factor and soluble Fms-like tyrosine kinase 1 and risk for preeclampsia
R Thadhani et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)
L Dugoff et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia
S Ahmad et al.
CIRCULATION RESEARCH (2004)
Prospective analysis of placenta growth factor (PIGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia
T Krauss et al.
HYPERTENSION IN PREGNANCY (2004)
The frequency and severity of placental findings in women with preeclampsia are gestational age dependent
JS Moldenhauer et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia
BM Polliotti et al.
OBSTETRICS AND GYNECOLOGY (2003)
Subclassification of preeclampsia
P von Dadelszen et al.
HYPERTENSION IN PREGNANCY (2003)
Increase in systolic blood pressure of >= 30 mm Hg and/or diastolic blood pressure of >= 15 mm Hg during pregnancy: Is it pathologic?
A Ohkuchi et al.
HYPERTENSION IN PREGNANCY (2003)
Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein a (PAPP-A), inhibin A, activin A, and soluble E-selectin
NA Bersinger et al.
HYPERTENSION IN PREGNANCY (2003)
Relationship between blood pressure level in early pregnancy and subsequent changes in blood pressure during pregnancy
R Iwasaki et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2002)
Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome
Y Yaron et al.
PRENATAL DIAGNOSIS (2002)
Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation
AM Martin et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2001)
Ambulatory blood pressure as predictor of preeclampsia in diabetic pregnancies with respect to urinary albumin excretion rate and glycemic regulation
FF Lauszus et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2001)
Long term mortality of mothers and fathers after pre-eclampsia:: population based cohort study
HU Irgens et al.
BRITISH MEDICAL JOURNAL (2001)
Plasma placenta growth factor levels in midtrimester pregnancies
ML Tjoa et al.
OBSTETRICS AND GYNECOLOGY (2001)
Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction
JP Granger et al.
HYPERTENSION (2001)
Decreased maternal serum placenta growth factor in early second trimester and preeclampsia
YN Su et al.
OBSTETRICS AND GYNECOLOGY (2001)
Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia
SC Tidwell et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2001)
Risk factors and clinical manifestations of pre-eclampsia
RA Odegård et al.
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2000)
First trimester maternal serum free β human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications
CYT Ong et al.
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2000)
Plasma endothelin-1 and mean arterial pressure in the prediction of pre-eclampsia
M Shaarawy et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2000)
The mercury sphygmomanometer should be abandoned before it is proscribed
ND Markandu et al.
JOURNAL OF HUMAN HYPERTENSION (2000)
Predictors of neonatal outcome in women with severe preeclampsia or eclampsia between 24 and 33 weeks' gestation
AG Witlin et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2000)
Can antenatal clinical and biochemical markers predict the development of severe preeclampsia?
DM Stamilio et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2000)
Share Paper
